EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming

Jiaxin Wu, Wanying Chen, Haijiang Qiu, Weihan Zheng iD, Ying Jiao, Jingheng Du, Zhudan Zhuang, Xing Hua, Jingyi Gu, Yuheng Liu, Zhaojin Li, Jingbin Xie and 9 more

Advanced Science · 2026-11 · 13 (62)

DOI: 10.1002/advs.77232 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-18. Written by Jiaxin Wu and 20 co-authors. Institution: International Ocular Surface Research Center, Institute of Ophthalmology, Key Laboratory for Regenerative Medicine, Jinan University, Guangzhou, Chin…. Major MEDLINE topics: Autophagy, Reactive Oxygen Species, Wound Healing, Macrophages. 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key R&D Program of China, National Natural Science Foundation of China Cross-disciplinary Major Research Program, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Impaired corneal wound healing in diabetes remains a major clinical challenge, driven by defective autophagy, metabolic dysregulation, and sustained inflammation within a high‐reactive oxygen species (ROS) microenvironment. Here, we engineered a ROS‐responsive ocular delivery system based on N1‐(4‐boronobenzyl)‐N3‐(4‐boronophenyl)‐N1, N1, N3, N3‐tetramethylpropane‐1,3‐diaminium (TSPBA)/poly(vinyl alcohol) (PVA) hydrogel microspheres (TP hydrogel microspheres) encapsulating 20‐deoxyingenol (20‐DOI), which enables sustained and ROS‐triggered drug release. Under high‐glucose conditions in vitro, which were used to model a diabetic microenvironment associated with elevated oxidative stress, TP/20‐DOI microspheres promoted macrophage polarization from the M1 phenotype toward the M2 phenotype. Transcriptomic and metabolic analyses indicated that this shift was driven by enhanced autophagy and concurrent metabolic rewiring from glycolysis to oxidative phosphorylation. In streptozotocin‐induced diabetic mice with corneal abrasions, topical TP/20‐DOI microspheres significantly accelerated re‐epithelialization and nerve regeneration while attenuating inflammation. The mechanism involved the autophagy‐dependent suppression of macrophage M1 polarization, which diminished the levels of macrophage‐derived C‐X‐C motif chemokine ligand 3 (CXCL3)/CXCL5 and neutrophil infiltration, as evidenced by the reversal of these effects upon pharmacological autophagy inhibition. Our findings establish an “autophagy–metabolism–polarization” axis as the core mechanism through which the microenvironment‐responsive TP/20‐DOI microspheres coordinate diabetic corneal repair, providing a blueprint for immunometabolic reprogramming therapies in ROS‐driven diabetic complications.

Subjects

MeSH terms (MEDLINE)

AutophagyReactive Oxygen SpeciesWound HealingMacrophagesDiabetes Mellitus, ExperimentalOphthalmic SolutionsCorneal InjuriesAnimalsMiceMetabolic ReprogrammingMice, Inbred C57BLMaleCorneaDiterpenes

Author keywords

20‐deoxyingenolautophagycorneal wound healingdiabetesinflammationmacrophage polarizationmetabolic reprogrammingmicrospheressmart‐responsive

Substances

Reactive Oxygen SpeciesOphthalmic Solutions20-deoxyingenolDiterpenes

Authors and institutions

  • International Ocular Surface Research Center, Institute of Ophthalmology, Key Laboratory for Regenerative Medicine, Jinan University, Guangzhou, China.
  • Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
  • Department of Immunology & Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.
  • Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, School of Medicine, Jinan University, Guangzhou, China.
  • Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou, China.
  • Department of Ophthalmology, Guangzhou First People's Hospital, Guangzhou, Guangdong, China.

ORCID profiles: Weihan Zheng, Zhijie Li, Guobing Chen, Shiyu Li, Jun Liu

Funding

  • National Key R&D Program of China
  • National Natural Science Foundation of China Cross-disciplinary Major Research Program
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation of China
  • Science and Technology Project in Guangzhou
  • Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences
  • Fundamental Research Funds for the Central Universities
  • Changzhi Medical College "1+1" Scientific Research Collaboration

Cite

APA

Wu, J., Chen, W., Qiu, H., Zheng, W., Jiao, Y., Du, J., Zhuang, Z., Hua, X., Gu, J., Liu, Y., Li, Z., Xie, J., Sun, H., Lan, H., Sun, X., Xue, Y., Fu, T., Li, Z., Chen, G., …, & Liu, J. (2026). ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming. Advanced Science, 13(62). https://doi.org/10.1002/advs.77232

Vancouver

Wu J, Chen W, Qiu H, Zheng W, Jiao Y, Du J, et al. ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming. Advanced Science. 2026;13(62). doi:10.1002/advs.77232

BibTeX
@article{Wu2026,
  author = {Wu, Jiaxin and Chen, Wanying and Qiu, Haijiang and Zheng, Weihan and Jiao, Ying and Du, Jingheng and Zhuang, Zhudan and Hua, Xing and Gu, Jingyi and Liu, Yuheng and Li, Zhaojin and Xie, Jingbin and Sun, Hanxiao and Lan, Huifei and Sun, Xin and Xue, Yunxia and Fu, Ting and Li, Zhijie and Chen, Guobing and Li, Shiyu and Liu, Jun},
  title = {ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {62},
  doi = {10.1002/advs.77232}
}
Start for free →